UBS Reiterates a 'Buy' on Allstate (ALL); Raising PT & Estimates on Better Margins

May 3, 2012 10:47 AM EDT Send to a Friend
Get Alerts ALL Hot Sheet
Price: $60.85 +0.35%

Rating Summary:
    12 Buy, 14 Hold, 1 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 37 | Down: 17 | New: 30
Trade ALL Now!
Join SI Premium – FREE
UBS reiterates a 'Buy' on Allstate (NYSE: ALL) price target from $37 to $38.

Analyst, Brian Meredith, said, "Compared to our forecasts, the upside surprise mainly involved favorable variances of $0.16 for underlying underwriting profit and lower corporate expenses ($0.02). Allstate began classifying certain limited partnership income ($0.12) as operating income in 1Q12. Excluding the reclassification, investment income was below our expectations in both P&C and Life. BVPS rose 4.5% vs originally reported 12/31/11 to $38.57 (below UBSe $39.39 and including a $0.75 hit for new DAC accounting)...We are increasing our EPS estimates from $3.92 to $4.25 for 2012 and from $4.15 to $4.25 for 2013."

For an analyst ratings summary and ratings history on Allstate click here. For more ratings news on Allstate click here.

Shares of Allstate closed at $32.91 yesterday.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Analyst Comments, Analyst EPS Change, Analyst EPS View, Analyst PT Change

Related Entities

UBS

Add Your Comment